This company has been marked as potentially delisted and may not be actively trading. Cyanotech (CYAN) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsEarningsInsider TradesShort InterestTrendsBuy This Stock CYAN vs. HAPP, SMFL, VYNE, KPRX, HCWB, ADXN, ENTO, CELZ, ALBT, and EVAXShould you be buying Cyanotech stock or one of its competitors? The main competitors of Cyanotech include Happiness Development Group (HAPP), Smart for Life (SMFL), VYNE Therapeutics (VYNE), Kiora Pharmaceuticals (KPRX), HCW Biologics (HCWB), Addex Therapeutics (ADXN), Entero Therapeutics (ENTO), Creative Medical Technology (CELZ), Avalon GloboCare (ALBT), and Evaxion A/S (EVAX). Cyanotech vs. Its Competitors Happiness Development Group Smart for Life VYNE Therapeutics Kiora Pharmaceuticals HCW Biologics Addex Therapeutics Entero Therapeutics Creative Medical Technology Avalon GloboCare Evaxion A/S Cyanotech (NASDAQ:CYAN) and Happiness Development Group (NASDAQ:HAPP) are both small-cap medicinals & botanicals industry companies, but which is the superior investment? We will compare the two businesses based on the strength of their dividends, profitability, analyst recommendations, institutional ownership, earnings, valuation, risk and media sentiment. Is CYAN or HAPP more profitable? Happiness Development Group has a net margin of 0.00% compared to Cyanotech's net margin of -19.50%. Happiness Development Group's return on equity of 0.00% beat Cyanotech's return on equity.Company Net Margins Return on Equity Return on Assets Cyanotech-19.50% -44.71% -19.12% Happiness Development Group N/A N/A N/A Does the media prefer CYAN or HAPP? In the previous week, Happiness Development Group had 1 more articles in the media than Cyanotech. MarketBeat recorded 1 mentions for Happiness Development Group and 0 mentions for Cyanotech. Happiness Development Group's average media sentiment score of 0.75 beat Cyanotech's score of 0.00 indicating that Happiness Development Group is being referred to more favorably in the news media. Company Overall Sentiment Cyanotech Neutral Happiness Development Group Positive Which has better earnings and valuation, CYAN or HAPP? Cyanotech has higher earnings, but lower revenue than Happiness Development Group. Cyanotech is trading at a lower price-to-earnings ratio than Happiness Development Group, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCyanotech$23.07M0.09-$5.27M-$0.66-0.44Happiness Development Group$95.59M0.04-$49.19M$0.481.14 Which has more risk & volatility, CYAN or HAPP? Cyanotech has a beta of -0.11, meaning that its share price is 111% less volatile than the S&P 500. Comparatively, Happiness Development Group has a beta of 0.23, meaning that its share price is 77% less volatile than the S&P 500. Do insiders & institutionals believe in CYAN or HAPP? 24.4% of Cyanotech shares are owned by institutional investors. Comparatively, 15.2% of Happiness Development Group shares are owned by institutional investors. 29.1% of Cyanotech shares are owned by company insiders. Comparatively, 15.6% of Happiness Development Group shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term. SummaryHappiness Development Group beats Cyanotech on 9 of the 13 factors compared between the two stocks. Get Cyanotech News Delivered to You Automatically Sign up to receive the latest news and ratings for CYAN and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CYAN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CYAN vs. The Competition Export to ExcelMetricCyanotechMedicinals & botanicals IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.08M$3.88B$6.15B$10.57BDividend YieldN/AN/A5.72%4.81%P/E Ratio-0.4410.0364.3622.95Price / Sales0.0978.10610.57131.84Price / CashN/A7.2437.1060.81Price / Book0.221.4312.236.52Net Income-$5.27M$19.57M$3.33B$276.93M Cyanotech Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CYANCyanotech0.5999 of 5 stars$0.29flatN/A-58.6%$2.08M$23.07M-0.4495HAPPHappiness Development GroupN/A$1.03-9.6%N/A-15.7%$7.16M$95.59M2.15215High Trading VolumeSMFLSmart for LifeN/A$0.00flatN/A-87.7%$19K$11.11M0.00110Gap DownVYNEVYNE Therapeutics2.0446 of 5 stars$0.39+5.9%$6.25+1,502.6%-82.7%$9.38M$500K-0.4330KPRXKiora Pharmaceuticals3.1313 of 5 stars$2.74+0.7%$10.00+265.0%-18.6%$9.34MN/A-0.9410News CoveragePositive NewsShort Interest ↓HCWBHCW Biologics2.2022 of 5 stars$4.50+6.6%$35.00+677.8%-82.2%$9.08M$832.84K-0.3240News CoverageShort Interest ↓ADXNAddex Therapeutics0.7365 of 5 stars$8.52flatN/A+3.3%$9.03M$460K-25.0630News CoverageAnalyst ForecastShort Interest ↓ENTOEntero TherapeuticsN/A$5.40-4.1%N/A+127.4%$8.94MN/A0.009News CoverageAnalyst ForecastShort Interest ↑Gap UpCELZCreative Medical Technology1.4084 of 5 stars$3.47+1.8%N/A-13.3%$8.80M$10K-1.095Positive NewsAnalyst ForecastALBTAvalon GloboCare0.9079 of 5 stars$2.24-2.2%N/A-15.2%$8.78M$1.33M-0.115Gap DownHigh Trading VolumeEVAXEvaxion A/S1.8952 of 5 stars$7.84+25.2%$11.00+40.3%-49.9%$8.78M$3.34M-5.9460Analyst ForecastShort Interest ↑Gap Down Related Companies and Tools Related Companies HAPP Competitors SMFL Competitors VYNE Competitors KPRX Competitors HCWB Competitors ADXN Competitors ENTO Competitors CELZ Competitors ALBT Competitors EVAX Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CYAN) was last updated on 10/18/2025 by MarketBeat.com Staff From Our PartnersREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredThis dark force is about to change everythingSomething unusual is unfolding inside the Republican Party — from Marjorie Taylor Greene breaking ranks to Ted...Porter & Company | SponsoredMove $1,000 into this stock before Nov 6The End of Tesla? "Hold onto your Tesla stock." That's the message insiders at Tesla have been giving staff...Altimetry | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredThe “smart money” is piling into one AI power company.Expert Reveals: The #1 Energy Play for 2025 "We're Entering the Greatest Energy Bull Market Since the Indus...Brownstone Research | SponsoredNext opportunity for crypto millionsThe floodgates have opened. Bitcoin and Ethereum ETFs are seeing record-breaking inflows, the biggest since...Crypto 101 Media | SponsoredElon’s Optimus to mint new “Musk Millionaires” as soon as Oct 23???Elon Musk may be set to create more "Musk Millionaires" as soon as October 23rd… Because on that day, he's exp...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cyanotech Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cyanotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
